Kajsa Appelberg
PhD student
Analysis of newborn screening (PKU-test) with health economic methods is my main focus. One of the first screening programs that was established, and is an essential part of preventive care.
Presentation
Screening programs are expensive, so it is important to weigh advantages and disadvantages against each other, as screening for one type of condition or disease replaces other resource utilization. Newborn screening (NBS) with the PKU-test can be described as a dynamic field that is in constant development. For example, it is analyzed whether new conditions should be added or some conditions removed from the screening programs, or if a new test method could be used to detect the conditions included in the program, and in these considerations, there is a strong need to use health economic analyzes as a foundation, which my thesis project aims to investigate. Furthermore, my research project aims to develop a method for analyzing the NBS and the uncertainties that comes with the long-time horizon of the effects that follows an individual through a life-time perspective.
Publications
2026
Cost-effectiveness of atrial fibrillation screening programmes across European nations
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 12, p. 83-92
(Article in journal)
https://dx.doi.org/10.1093/ehjqcco/qcaf099
2024
The budget impact of implementing atrial fibrillation-screening in European countries
European Heart Journal, Supplement, Vol. 26, p. iv19-iv32
(Article in journal)
https://dx.doi.org/10.1093/eurheartjsupp/suae076
2023
Cost-Effectiveness of Newborn Screening for Phenylketonuria and Congenital Hypothyroidism
The Journal of Pediatrics, Vol. 256, p. 38-43.e3
(Article in journal)
https://dx.doi.org/10.1016/j.jpeds.2022.10.046